Previous 10 | Next 10 |
2023-05-15 07:15:14 ET Shares of ANI Pharmaceuticals ( NASDAQ: ANIP ) spiked in the pre-market Monday after announcing that the FDA approved the market entry of the company’s generics for seizure therapy Celontin and osteoporosis drug RLD Fosamax Oral Solution. In approvi...
IQVIA (NYSE:IQV) today announced that Sheetal Telang, vice president of Therapeutic Strategy, has been honored with the 2023 Rising Star award by the Healthcare Businesswoman's Association (HBA). Sheetal earned the award for her strong and innovative leadership, combined with her exemplary wo...
2023-05-09 15:23:46 ET The Federal Trade Commission is investigating IQVIA Holdings ( NYSE: IQV ) planned purchase of Propel Media, which owns an advertising tech company used by many drugmakers. IQVIA is paying $700M-$800M for Propel Media, which owns DeepIntent, Politico r...
2023-05-07 12:00:27 ET Patients in the U.S are expected to dish out $10B on obesity medicines in 2027, marking an $8.1B rise or over 378% growth for the period 2023 – 2027, the latest industry report on pharma spending from the drug analytics firm IQVIA Holdings ( IQV ) indicates...
2023-05-02 15:43:45 ET The U.S. Food and Drug Administration (FDA) on Tuesday issued a draft guidance to offer further support for decentralized clinical trials (DCTs) where studies for treatments and medical devices can take place beyond traditional trial sites. DCTs can lower the barr...
The U.S. market for medicines grew by 5% in 2022, reaching a total value of $429Bn Health services utilization reached 100% of pre-pandemic levels for the first time at the end of 2022, up from a low of 66% in Q2 of 2020 Telehealth visits fell to 5% of total visits in 2022, down f...
2023-04-27 14:33:00 ET IQVIA Holdings ( NYSE: IQV ) and ICON Public Limited ( NASDAQ: ICLR ) led decliners in the contract research space Thursday after the companies reiterated the guidance despite reporting better-than-expected Q1 2023 financials. IQV shares have reach...
2023-04-27 12:25:11 ET IQVIA Holdings Inc. (IQV) Q1 2023 Earnings Conference Call April 27, 2023, 09:00 AM ET Company Participants Nick Childs - Senior Vice President, Investor Relations and Treasurer Ari Bousbib - Chairman and Chief Executive Officer Ron Bruehlm...
2023-04-27 07:10:21 ET IQVIA press release ( NYSE: IQV ): Q1 Non-GAAP EPS of $2.45 beats by $0.04 . Revenue of $3.65B (+2.2% Y/Y) beats by $40M . Shares -1.31% PM. Reaffirms full-year 2023 guidance For further details see: IQVIA Non-GAAP E...
Revenue of $3,652 million GAAP Net Income of $289 million, Adjusted EBITDA of $851 million GAAP Diluted Earnings per Share of $1.53, Adjusted Diluted Earnings per Share of $2.45 R&D Solutions quarterly bookings of $2.6 billion, representing book-to-bill ratio of 1.28x ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 10:00:13 ET Jailendra Singh from Truist Financial issued a price target of $300.00 for IQV on 2024-07-23 09:26:00. The adjusted price target was set to $300.00. At the time of the announcement, IQV was trading at $240.265. The overall price target consensus is...
2024-07-23 10:00:11 ET Elizabeth Anderson from Evercore ISI issued a price target of $270.00 for IQV on 2024-07-23 08:59:00. The adjusted price target was set to $270.00. At the time of the announcement, IQV was trading at $239.5. The overall price target consensus is at...
2024-07-23 07:00:06 ET Luke Sergott from Barclays issued a price target of $275.00 for IQV on 2024-07-23 05:25:00. The adjusted price target was set to $275.00. At the time of the announcement, IQV was trading at $245.23. The overall price target consensus is at $273.93 ...